| P50 | author | Daisuke Kadowaki | Q50600194 |
| | Yuki Kondo | Q59705484 |
| | Yoichi Ishitsuka | Q73209250 |
| P2093 | author name string | Tetsumi Irie | |
| | Mitsuru Irikura | |
| | Minako Nagatome | |
| | Yusuke Saishyo | |
| P2860 | cites work | Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity | Q46635865 |
| | Preparation of hydrophilic C60(OH)10/2-hydroxypropyl-β-cyclodextrin nanoparticles for the treatment of a liver injury induced by an overdose of acetaminophen. | Q46775419 |
| | Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis models | Q46814306 |
| | Combination of tauroursodeoxycholic acid and N-acetylcysteine exceeds standard treatment for acetaminophen intoxication | Q48279965 |
| | Dual Role of Epidermal Growth Factor Receptor in Liver Injury and Regeneration after Acetaminophen Overdose in Mice | Q48857460 |
| | beta-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration. | Q50536776 |
| | Suppression of Mitochondrial Succinate Dehydrogenase, a Primary Target of β‐Amyloid, and Its Derivative Racemized at Ser Residue | Q50756222 |
| | The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides. | Q50760156 |
| | Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice. | Q54343153 |
| | Evaluation of three-dimensional cultured HepG2 cells in a nano culture plate system: an in vitro human model of acetaminophen hepatotoxicity. | Q54379972 |
| | Mitochondrial protection by the JNK inhibitor leflunomide rescues mice from acetaminophen-induced liver injury | Q79967745 |
| | Ethyl pyruvate: a novel anti-inflammatory agent | Q80054477 |
| | Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury | Q80077527 |
| | Ethyl pyruvate: a novel treatment for sepsis | Q80149302 |
| | Preliminary safety and biological efficacy studies of ethyl pyruvate in normal mature horses | Q83861637 |
| | Aldo-keto reductase-7A protects liver cells and tissues from acetaminophen-induced oxidative stress and hepatotoxicity | Q84396286 |
| | Sterile inflammation in acute liver injury: myth or mystery? | Q26799490 |
| | Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries | Q28068263 |
| | Targeting Pink1-Parkin-mediated mitophagy for treating liver injury | Q28082937 |
| | Acetaminophen-induced hepatotoxicity | Q28185453 |
| | Mechanisms of hepatotoxicity | Q28216749 |
| | Chronic Deletion and Acute Knockdown of Parkin Have Differential Responses to Acetaminophen-induced Mitophagy and Liver Injury in Mice | Q28392505 |
| | Paracetamol poisonings in the Czech and Slovak Republic and N-acetylcysteine treatment. Data analysis | Q30886845 |
| | Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation | Q34156078 |
| | Ozagrel hydrochloride, a selective thromboxane A₂ synthase inhibitor, alleviates liver injury induced by acetaminophen overdose in mice. | Q34567487 |
| | Overdose pattern and outcome in paracetamol-induced acute severe hepatotoxicity | Q34580637 |
| | The impact of partial manganese superoxide dismutase (SOD2)-deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity | Q34630779 |
| | Apoptosis-inducing factor modulates mitochondrial oxidant stress in acetaminophen hepatotoxicity | Q35161427 |
| | Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity | Q35718640 |
| | Ethyl pyruvate reduces liver injury at early phase but impairs regeneration at late phase in acetaminophen overdose | Q36093484 |
| | Prevalence, Severity, and Impact of Renal Dysfunction in Acute Liver Failure on the US Liver Transplant Waiting List | Q36437169 |
| | Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule | Q36461570 |
| | Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products. | Q36718265 |
| | Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs | Q36930476 |
| | Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis | Q37004604 |
| | The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds | Q37709590 |
| | Pyruvate antioxidant roles in human fibroblasts and embryonic stem cells | Q38714417 |
| | HMGB1/RAGE axis promotes autophagy and protects keratinocytes from ultraviolet radiation-induced cell death | Q38724486 |
| | Trends in rates of acetaminophen-related adverse events in the United States | Q38946697 |
| | Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure | Q39027620 |
| | Phosphoenolpyruvate, a glycolytic intermediate, as a cytoprotectant and antioxidant in ex-vivo cold-preserved mouse liver: a potential application for organ preservation. | Q39203445 |
| | N-acetylcysteine does not protect HepG2 cells against acetaminophen-induced apoptosis | Q40559497 |
| | Comparative Effects of Phosphoenolpyruvate, a Glycolytic Intermediate, as an Organ Preservation Agent with Glucose and N-Acetylcysteine against Organ Damage during Cold Storage of Mouse Liver and Kidney | Q41875280 |
| | Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria | Q41956652 |
| | N-acetylcysteine amide, a promising antidote for acetaminophen toxicity | Q42700054 |
| | Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells | Q44625379 |
| | CHOP is a critical regulator of acetaminophen-induced hepatotoxicity. | Q44693987 |
| | Ethyl pyruvate protects PC12 cells from dopamine-induced apoptosis | Q45243969 |
| | Comparison of S-Adenosyl-L-methionine and N-acetylcysteine protective effects on acetaminophen hepatic toxicity | Q45302974 |
| | A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypass | Q46331601 |
| | Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment Ameliorate Acetaminophen-Induced Liver Injury in Mice via Central Cholinergic System Regulation | Q46477020 |
| P433 | issue | 2 | |
| P304 | page(s) | e00521 | |
| P577 | publication date | 2018-02-01 | |
| P1433 | published in | Heliyon | Q27727019 |
| P1476 | title | Ethyl pyruvate attenuates acetaminophen-induced liver injury and prevents cellular injury induced by N-acetyl-p-benzoquinone imine | |
| P478 | volume | 4 | |